nature clinical practice rheumatology | 2006(06) articles
- European rheumatology is advancing
- Science as experiment; science as observation
- Nonresponse to tumor necrosis factor antagonists-is there any point in re-treatment?
- Exercise in water is beneficial for patients with fibromyalgia
- Increased lymphoma risk associated with high disease activity in rheumatoid arthritis
- Levels of molecular biomarkers can predict rate of disease progression in osteoarthritis
- Data analysis supports the existence of subtypes of systemic lupus erythematosus
- Animal study shows antiresorptive agent has novel mechanism of action
- How can we avoid the prescription of contraindicated drugs?
- Psoriatic arthritis can be difficult to distinguish from rheumatoid arthritis
- Which patients could benefit from early biologic therapy for rheumatoid arthritis?
- Early, high BMI linked with increased risk of total-hip arthroplasty in patients with OA
- New onset or exacerbation of psoriasis during tumor necrosis factor inhibition
- BMD predicts osteoporosis in recently postmenopausal women
- Are patients with rheumatoid arthritis prone to accelerated atherosclerosis?
- Denosumab improves low BMD in postmenopausal women
- Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy
- Treating axial manifestations in ankylosing spondylitis in the presence of peripheral arthritis
- Efficacy and safety of infliximab for the treatment of psoriatic arthritis
- Do nonsteroidal anti-inflammatory drugs accelerate disease progression in osteoarthritis?
- Prospects for disease modification in osteoarthritis
- Primer: assessing the efficacy and safety of nonpharmacologic treatments for chronic rheumatic diseases
- Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis
- Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus
- Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol